Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		242,738,000
Beginning balance at Dec. 31, 2021	$ 929,787	$ 24	$ 1,515,748	$ (1,623)	$ (584,362)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		3,513,000
Issuance of common stock upon exercise of stock options	9,252	$ 1	9,251
Issuance of common stock under employee stock purchase plan (in shares)		284,000
Issuance of common stock under employee stock purchase plan	887		887
Issuance of common stock in connection with restricted stock units, net of tax (in shares)		105,000
Issuance of common stock in connection with restricted stock units, net of tax	(367)		(367)
Stock-based compensation (in shares)		2,600,000
Stock-based compensation	63,561		63,561
Other comprehensive income (loss)	(8,373)			(8,373)
Net loss	(174,721)				(174,721)
Ending balance (in shares) at Sep. 30, 2022		249,240,000
Ending balance at Sep. 30, 2022	820,026	$ 25	1,589,080	(9,996)	(759,083)
Beginning balance (in shares) at Jun. 30, 2022		247,110,000
Beginning balance at Jun. 30, 2022	868,042	$ 25	1,565,197	(8,351)	(688,829)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		1,375,000
Issuance of common stock upon exercise of stock options	5,127		5,127
Issuance of common stock in connection with restricted stock units, net of tax (in shares)		105,000
Issuance of common stock in connection with restricted stock units, net of tax	(367)		(367)
Stock-based compensation (in shares)		650,000
Stock-based compensation	19,123		19,123
Other comprehensive income (loss)	(1,645)			(1,645)
Net loss	(70,254)				(70,254)
Ending balance (in shares) at Sep. 30, 2022		249,240,000
Ending balance at Sep. 30, 2022	$ 820,026	$ 25	1,589,080	(9,996)	(759,083)
Beginning balance (in shares) at Dec. 31, 2022	249,567,343	249,567,000
Beginning balance at Dec. 31, 2022	$ 833,252	$ 25	1,608,306	(7,599)	(767,480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	1,478,537	1,479,000
Issuance of common stock upon exercise of stock options	$ 155		155
Issuance of common stock under employee stock purchase plan (in shares)		543,000
Issuance of common stock under employee stock purchase plan	1,163		1,163
Issuance of common stock in connection with restricted stock units, net of tax (in shares)		280,000
Issuance of common stock in connection with restricted stock units, net of tax	(334)		(334)
Stock-based compensation	38,621		38,621
Other comprehensive income (loss)	6,418			6,418
Net loss	$ (181,702)				(181,702)
Ending balance (in shares) at Sep. 30, 2023	251,868,968	251,869,000
Ending balance at Sep. 30, 2023	$ 697,573	$ 25	1,647,911	(1,181)	(949,182)
Beginning balance (in shares) at Jun. 30, 2023		251,027,000
Beginning balance at Jun. 30, 2023	736,855	$ 25	1,637,538	(2,379)	(898,329)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		646,000
Issuance of common stock upon exercise of stock options	72		72
Issuance of common stock in connection with restricted stock units, net of tax (in shares)		196,000
Issuance of common stock in connection with restricted stock units, net of tax	(215)		(215)
Stock-based compensation	10,516		10,516
Other comprehensive income (loss)	1,198			1,198
Net loss	$ (50,853)				(50,853)
Ending balance (in shares) at Sep. 30, 2023	251,868,968	251,869,000
Ending balance at Sep. 30, 2023	$ 697,573	$ 25	$ 1,647,911	$ (1,181)	$ (949,182)